Skip to Content

McKesson Corp MCK Stock Quote

| Rating as of


Last close prices updated as of Feb 06, 2023, 4:10 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 362.58
  • Sector Healthcare
  • Industry Medical Distribution
  • Investment Style Large Blend
  • Day Range 357.64  –  367.00
  • Year Range 260.73  –  401.78
  • Market Cap 49.0420 Bil
  • Volume / Avg 1.3 Mil /  1.1 Mil
  • Price / Sales 0.19
  • Price / Book 4.88
  • Forward Div Yield 0.60%
  • Trailing Div Yield 0.71%

Morningstar‘s Stock Analysis MCK

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Narrow-Moat McKesson Reports Solid Third-Quarter Earnings; FVE Remains $348

Keonhee Kim Equity Analyst

Analyst Note

| Keonhee Kim |

Narrow-moat McKesson reported third-quarter earnings today that were in line with our expectations. We maintain our fair value estimate of $348 per share. Top line for the quarter was up 2.7% year over year, driven by U.S. pharmaceutical (up 12.5%) and prescription technology solutions (up 8.7%). U.S. pharmaceutical sales were bolstered by increased volume of specialty products, which usually comes at a higher cost compared with generic and branded drugs, as well as higher volume from retail accounts. Increased prescription volumes also flowed nicely into the prescription technology solutions segment as it drove higher growth for pharmacy technology services. McKesson’s other two segments saw continued weak performance, as medical-surgical solutions and international were down for the quarter 3.1% and 53.0%, respectively. Strong contributions from COVID-19 vaccines and tests in 2021 resulted in tough comparisons for medical-surgical, and we expect lower sales from both items in the future. The international segment suffered as McKesson continued its European divestitures and experienced currency headwinds. Over the long term, we expect the company’s international business to stabilize and post a normalized level of growth (low- to mid-single-digit).

Unlock Our Full Analysis With Morningstar Investor

Key Statistics MCK

Company Profile MCK

Business Description

McKesson Corp is one of three leading pharmaceutical wholesalers in the U.S. engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for over 90% of the U.S. pharmaceutical wholesale industry. Outside the U.S. market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

6555 State Highway 161
Irving, TX, 75039
Industry Medical Distribution
Employees 75,000

Related Articles MCK

FAQs for McKesson Corp Stock

Yes. MCK has a forward dividend yield of 0.60%. See MCK’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

MCK’s market cap is 49.04 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

MCK’s stock style is Large Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

MCK’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare MCK’s historical performance against its industry peers and the overall market.